Liqio Exchange

Liqio Exchange

ICO Ended
5,424 Views
LIQIO is an Estonian registered company (LIQIO Oรœ 1478949). The company has an address in Estonia and offices in Western Europe. When you purchase LQO tokens, you will receive dividends once a month. 50% of the fees collected by the exchange will be paid to the holder of the LQO token. Community trading: follow the best traders In partnership with Shillerz.
8.1
TOTAL SCORE
8.1
ICO PROFILE

(weight: 45%)

10
TEAM PROOF

(weight: 20%)

Get widget
General
Website: Visit
White paper: Read
Bounty: Bounty
ICO Time: 21 Dec 2019 - 21 Feb 2020
Whitelist/KYC: KYC
Country: Estonia
Token info
Ticker: LQO
Platform: Ethereum
Token Type: ERC-20
Available for sale: 70,000,000 LQO (70%)
Total supply: 100,000,000 LQO
Financial
ICO Price: 1 LQO = 0.026 USD
Accepting: ETH,BTC
Soft cap: 550,000 USD
Hard cap: 1,820,000 USD
Q3-Q4 2019
LIQIO launch.<br /> Obtaining Wallet and Exchange licenses in Estonia.<br /> Start of the token sale in December
Q4 2019 - Q2 2020
Development of the IEO platform.<br /> Increasing the capacity of the trading engine.<br /> Development of the community trading platform.
Q2-Q3 2020
Launch of the community trading platform.<br /> Launch of the IEO platform.<br /> Increasing the capacity of the trading engine.<br /> Development of iOS and Android applications.
Q4 2020
Development of a function chosen by the community.<br /> Increasing the capacity of the trading engine.<br /> Launch of iOS and Android applications.
Screenshots taken on 31 Dec 2019
David Blocry
Chief Growth Officer
Participates in a number of projects
Mathieu Lucet
Chief Technical Officer
Participates in a number of projects
Baptiste Bulvestre
Chief Executive Officer
Participates in a number of projects

Advisors (0)

HEIGHT - 0px
WIDTH - 0px
PUT THIS CODE TO YOUR WEBSITE
ICO List
Other Interesting ICOs
Upcoming
Unchainet
UNCHAINET connects underutilized server resources with clients who need them. Our blockchain protocols govern the network, align provider incentives with computing resource quality giving choices and transparency to the cloud client market.
Upcoming
AllPublicArt
All Public Art (APA) provides a unique platform that contributes to the growth and sustainability of the global art community by supporting the art market, igniting artist-to-collector trading, and storing the provenance of art on the blockchain. With the AllPublicArt token and the creation of our API, we are deploying a new, convenient and effective way to trade art and track the history of artworks. All Public Art's implementation of blockchain technology will minimize counterfeit art, build trust within the art market, improve art trade services and increase economic and social benefits in the global art community. Thanks to blockchain technology, transparency is increased ensuring a more convenient and legitimate marketplace for trading art.
Upcoming
Verifier
Verifier is an innovative technology designed to verify identity, events, deals, and any other kind of data. This is a blockchain based solution that verifies data quickly, accurately, trustworthy, and securely.
Upcoming
DINNGO
The first exchange to enable simple two step verification with mobile device and cold wallet. Dinngo is revolutionising the way we trade digital currencies. Our cold wallet integrates seamlessly with the Dinngo exchange, providing the secure, fast and convenient asset trading service the market needs.
Upcoming
Pharmeum
Pharmeum is the world's first blockchain-based prescription platform with AI health analytics, which is currently working alongside the National Health Service (NHS) in England. The Pharmeum platform is an inter-operable, decentralised, digital prescription platform running over an intelligent neural network. Empowering patientsโ€™ ownership of their medication history, and enabling affordable access to healthcare globally. Medical errors and late diagnoses are minimised by using a permissioned blockchain integrated with artificial intelligence. Pharmeum is an advanced, digitised, health eco-system.The Pharmeum blockchain will improve medicine affordability, minimise errors, and create frictionless, quality care for patients.
Upcoming
MeFy
Mefy works on a subscription-based model, where the user of MeMe Care subscribes for yearly subscription allowing them any number of tests throughout the year for the cost of just consumables. Through its eConsult feature it connects worldwide doctors to worldwide patients thereby resolving accessibility issues and with its MeMe Edge device, it provides authenticity to the test conducted.